Mason Street Advisors’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-26,759
| Closed | -$933K | – | 887 |
|
|
2020
Q4 | $933K | Sell |
26,759
-103
| -0.4% | -$3.66K | 0.02% | 967 |
|
|
2020
Q3 | $978K | Sell |
26,862
-584
| -2% | -$21.7K | 0.02% | 830 |
|
|
2020
Q2 | $1.03M | Buy |
27,446
+728
| +3% | +$29.1K | 0.02% | 811 |
|
|
2020
Q1 | $980K | Hold |
26,718
| – | – | 0.02% | 737 |
|
|
2019
Q4 | $1.08M | Buy |
26,718
+371
| +1% | +$13.8K | 0.02% | 850 |
|
|
2019
Q3 | $914K | Sell |
26,347
-1,262
| -5% | -$41.6K | 0.02% | 883 |
|
|
2019
Q2 | $875K | Buy |
27,609
+64
| +0.2% | +$1.9K | 0.02% | 905 |
|
|
2019
Q1 | $824K | Buy |
27,545
+445
| +2% | +$12.8K | 0.02% | 961 |
|
|
2018
Q4 | $837K | Buy |
27,100
+529
| +2% | +$19.3K | 0.02% | 859 |
|
|
2018
Q3 | $1.01M | Sell |
26,571
-650
| -2% | -$24.6K | 0.02% | 872 |
|
|
2018
Q2 | $1.04M | Buy |
27,221
+581
| +2% | +$19.6K | 0.02% | 853 |
|
|
2018
Q1 | $898K | Buy |
26,640
+509
| +2% | +$19.5K | 0.02% | 870 |
|
|
2017
Q4 | $1.16M | Sell |
26,131
-175
| -0.7% | -$7.97K | 0.03% | 808 |
|
|
2017
Q3 | $1.32M | Buy |
26,306
+438
| +2% | +$22.4K | 0.03% | 734 |
|
|
2017
Q2 | $1.37M | Buy |
25,868
+860
| +3% | +$46.1K | 0.03% | 703 |
|
|
2017
Q1 | $1.39M | Buy |
25,008
+303
| +1% | +$16.7K | 0.04% | 676 |
|
|
2016
Q4 | $1.29M | Buy |
24,705
+221
| +0.9% | +$10.7K | 0.03% | 693 |
|
|
2016
Q3 | $1.18M | Buy |
24,484
+424
| +2% | +$21.4K | 0.03% | 711 |
|
|
2016
Q2 | $1.33M | Buy |
24,060
+14,682
| +157% | +$809K | 0.04% | 621 |
|
|
2016
Q1 | $501K | Buy |
9,378
+877
| +10% | +$43.2K | 0.02% | 902 |
|
|
2015
Q4 | $438K | Buy |
8,501
+733
| +9% | +$36.4K | 0.01% | 909 |
|
|
2015
Q3 | $351K | Buy |
7,768
+544
| +8% | +$25.7K | 0.01% | 941 |
|
|
2015
Q2 | $334K | Buy |
7,224
+283
| +4% | +$12.4K | 0.01% | 956 |
|
|
2015
Q1 | $298K | Sell |
6,941
-132,161
| -95% | -$5.04M | 0.01% | 970 |
|
|
2014
Q4 | $4.83M | Buy |
139,102
+227
| +0.2% | +$7.53K | 0.03% | 552 |
|
|
2014
Q3 | $4.5M | Sell |
138,875
-28
| -0% | -$937 | 0.04% | 551 |
|
|
2014
Q2 | $4.71M | Buy |
138,903
+188
| +0.1% | +$6.02K | 0.04% | 563 |
|
|
2014
Q1 | $3.78M | Buy |
138,715
+3,749
| +3% | +$111K | 0.03% | 640 |
|
|
2013
Q4 | $4.83M | Buy |
134,966
+17,843
| +15% | +$593K | 0.04% | 529 |
|
|
2013
Q3 | $3.53M | Buy |
117,123
+110,036
| +1,553% | +$3.6M | 0.04% | 469 |
|
|
2013
Q2 | $207K | Buy |
+7,087
| New | +$200K | ﹤0.01% | 1205 |
|
Other funds holding PBH
TCAM
CIP
Mason Street Advisors's PBH Position: Q1 2021 in Review
Mason Street Advisors sold out of Prestige Consumer Healthcare (PBH) in Q1 2021, closing a stake of 26,759 shares — an estimated $933K sold.
Mason Street Advisors first reported a position in PBH in Q2 2013 and held it in 31 quarters. The position peaked at $4.83M in Q4 2013. 241 funds tracked by Wall St. Rank hold PBH as of Q1 2021.
- Mason Street Advisors reported no remaining Prestige Consumer Healthcare position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 26,759 Prestige Consumer Healthcare shares in Q1 2021, an estimated $933K.
- Mason Street Advisors first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 31 quarters.
- Mason Street Advisors's Prestige Consumer Healthcare position peaked at $4.83M in Q4 2013.
- 241 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.